Emerson Delacroix

Mx. Emerson Delacroix

Health Behavior & Health Education, University of Michigan, Ann Arbor, Michigan, USA
+2
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2022 in Journal of Genetic Counseling
Verified
Journal Article
Open access
KRKen Resnicow
Ken Resnicow
EDEmerson Delacroix
Emerson Delacroix
GCGabriela Chen
Gabriela Chen
SASarah Austin
Sarah Austin
ESElena Stoffel
Elena Stoffel
DCDeborah Cragun
Deborah Cragun
Genetic counselors (GCs) have traditionally been trained to adopt a position of equipoise or clinical neutrality. They provide information, answer questions, address barriers, and engage in shared decision‐making, but generally, they do not prescribe a genetic test. Historically, GCs have generally been trained not to persuade the ambivalent or resistant patient. More recently, however, there has been discussion regarding when a greater degree of persuasion or directionality may be appropriate within genetic counseling (GC) and what role MI may play in this process. The role for “persuasive GC” is based on the premise that some genetic tests provide actionable information that would clearly benefit patients and families by impacting treatment or surveillance. For other tests, the benefits are less clear as they do not directly impact patient care or the benefits may be more subjective in nature, driven by patient values or psychological needs. For the former, we propose that GCs may adopt a more persuasive clinical approach while for the latter, a more traditional equipoise stance may be more appropriate. We suggest that motivational interviewing (MI) could serve as a unifying counseling model that allows GCs to handle both persuasive and equipoise encounters. For clearly beneficial tests, while directional, the MI encounter can still be non‐directive, autonomy‐supportive, and patient‐centered. MI can also be adapted for equipoise situations, for example, placing less emphasis on eliciting and strengthening change talk as that is more a behavior change strategy than a shared decision‐making strategy. The core principles and strategies of MI, such as autonomy support, evocation, open questions, reflective listening, and affirmation would apply to both persuasive and equipoise encounters. Key issues that merit discussion include how best to train GCs both during their initial and post‐graduate education.

27 May 2024 in Journal of Genetic Counseling
Verified
Journal Article
Open access
SASarah Austin
Sarah Austin
EHErika N. Hanson
Erika N. Hanson
EDEmerson Delacroix
Emerson Delacroix
EBElizabeth Bacon
Elizabeth Bacon
JRJohn Rice
John Rice
KRKen Resnicow
Ken Resnicow
Genetic testing for hereditary cancer syndromes can provide lifesaving information allowing for individualized cancer screening, prevention, and treatment. However, the determinants, both barriers and motivators, of genetic testing intention are not well described. A survey of barriers and motivators to genetic testing was emailed to adult patients eligible for genetic testing based on cancer diagnosis who previously have not had genetic testing (n = 201). Associations between barriers/motivators with testing intention and confidence were examined first by correlation followed by multivariable linear regression model holding constant potential covariates. Seven barrier items from two domains (logistics and genetic testing knowledge) were found to significantly negatively correlate with genetic testing intention. Unexpectedly, three barrier items had significant positive correlation with genetic testing intention; these were related to family worry (passing a condition on to future generations) and testing knowledge (needing more information on the genetic testing process and what it has to offer). Ten barrier items had significant negative correlation with confidence to get a genetic test and encompassed four domains: stigma, insurance/genetic discrimination, knowledge, and cost. All motivator items were associated with intention to get a genetic test, while none were associated with confidence. Multivariable analysis yielded six total barriers (five from the knowledge domain, one from cost domain) and two motivators (relieved to know and treatment impact) that were significantly associated with genetic testing intention or confidence when controlling for demographic characteristics. These findings indicate the need for tailored interventions to amplify motivating factors and counter‐message barriers to enhance patient motivation and confidence to undergo testing.

19 February 2023 in Cancer Medicine
Verified
Journal Article
Open access
EHErika N. Hanson
Erika N. Hanson
EDEmerson Delacroix
Emerson Delacroix
SASarah Austin
Sarah Austin
GCGrant Carr
Grant Carr
KKKelley M. Kidwell
Kelley M. Kidwell
KRKen Resnicow
Ken Resnicow
Background: Only a small proportion of patients who qualify for clinical genetic testing for cancer susceptibility get testing. Many patient‐level barriers contribute to low uptake. In this study, we examined self‐reported patient barriers and motivators for cancer genetic testing.Methods: A survey comprised of both new and existing measures related to barriers and motivators to genetic testing was emailed to patients with a diagnosis of cancer at a large academic medical center. Patients who self‐reported receiving a genetic test were included in these analyses (n = 376). Responses about emotions following testing as well as barriers and motivators prior to getting testing were examined. Group differences in barriers and motivators by patient demographic characteristics were examined.Results: Being assigned female at birth was associated with increased emotional, insurance, and family concerns as well as increased health benefits compared to patients assigned male at birth. Younger respondents had significantly higher emotional and family concerns compared to older respondents. Recently diagnosed respondents expressed fewer concerns about insurance implications and emotional concerns. Those with a BRCA‐related cancer had higher scores on social and interpersonal concerns scale than those with other cancers. Participants with higher depression scores indicated increased emotional, social and interpersonal, and family concerns.Conclusions: Self‐reported depression emerged as the most consistent factor influencing report of barriers to genetic testing. By incorporating mental health resources into clinical practice, oncologists may better identify those patients who might need more assistance following through with a referral for genetic testing and the response afterwards.

14 June 2025 in Cancers
Verified
Journal Article
Open access
PDF file
EDEmerson Delacroix
Emerson Delacroix
SASarah Austin
Sarah Austin
JRJohn D. Rice
John D. Rice
ESElena Martinez Stoffel
Elena Martinez Stoffel
EKErika Koeppe
Erika Koeppe
KRKen Resnicow
Ken Resnicow
Background: Despite clinical utility in managing hereditary cancers, genetic testing (GT) remains underutilized. While barriers include knowledge gaps and cost, clinician recommendation is a major driver of GT uptake, with rates varying by cancer type and family cancer history documentation. Methods: Adult participants (≥18 years) were recruited through multiple sources to complete a cancer family history survey for a larger intervention trial. Participants with personal or family history indicating increased hereditary cancer risk who had not undergone GT (N = 3001) were invited to complete a baseline survey. Multivariable logistic regression was used to analyze associations between demographics and cancer history by receipt of a clinician recommendation for GT. Results: Among 784 respondents, most were White (84.6%), female (58.4%), and over age 51 (75.3%), with 58.2% reporting a diagnosis of cancer. Only 14.0% reported receiving a clinician recommendation for GT, with lower recommendation rates among younger adults (20.1%), those reporting no financial stress (10.7%), and those with higher education (12.0%). Multivariate analysis showed participants who did not report financial stress (p = 0.049) were less likely to receive a recommendation. Discussion: These findings highlight disparities in GT recommendation by clinicians. Increased clinician education about indications for GT, the implementation of electronic medical record tools to facilitate the identification of patients with guideline-concordant personal and/or biological-relative cancer history, and patient-facing interventions could standardize the dissemination of recommendations for GT. Conclusions: Future efforts that focus on increasing clinician education and electronic decision support should identify individuals with personal and/or biological-relative cancer history meeting criteria for GT.

9 May 2025 in Patient Education and Counseling
Verified
Journal Article
Open access
EMEden Moore
Eden Moore
JVJessica Vallejo
Jessica Vallejo
MSMargo A. Sidell
Margo A. Sidell
XLXia Li
Xia Li
EDEmerson Delacroix
Emerson Delacroix
CKCorinna Koebnick
Corinna Koebnick
To determine the association between motivational interviewing (MI) training for pediatricians and the caregiver's uptake of health behavior and lifestyle treatment (HBLT) during the Wellness Coaching for Kids (WC4K) implementation study. Pediatricians from 24 (of 49) randomly assigned pediatric clinics across Southern California were trained in MI to motivate and refer eligible caregivers to engage in HBLT beginning in 2022. Eligible children were 3-8 years old at the time of their caregiver's referral to HBLT, with a body mass index (BMI) ≥ 85th percentile for age and sex. Two years after the program started, we analyzed the proportion of referred caregivers who engaged in HBLT coaching by the pediatricians' MI-training status. Among 233 pediatricians from 24 intervention clinics, 53 % (n = 123) participated in MI training, and 44 % (n = 102) referred at least one caregiver to HBLT coaching. Out of 19,888 eligible children, 10.3 % (n = 2045) were referred to wellness coaching (reached). The reach was higher in MI-trained compared to untrained pediatricians (20.4 ± 10.1 % and 7.0 ± 10.2 %, respectively, p = 0.003). Among those referred, 49.9 % (n = 1021) scheduled a coaching appointment, and 43.3 % (n = 886) received at least one coaching call (uptake). The uptake among caregivers with MI-trained pediatricians was significantly higher (aOR 2.3; 95 %CI 1.4, 3.6) than among those with untrained pediatricians. Caregiver uptake of HBLT was higher when referred by MI-trained pediatricians, suggesting MI can be successful in brief interventions to engage families in initiating HBLT for childhood obesity in primary care.

1 August 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
JNJulie A Wright Nunes
Julie A Wright Nunes
KRKen Resnicow
Ken Resnicow
CRCaroline Richardson
Caroline Richardson
DLDiane Levine
Diane Levine
EKEve Kerr
Eve Kerr
AFAngela Fagerlin
Angela Fagerlin
Introduction Chronic kidney disease (CKD) affects 30 million Americans. Early management focused on blood pressure (BP) control decreases cardiovascular morbidity and mortality. Less than 40% of patients with CKD achieve recommended BP targets due to many barriers. These barriers include a lack of understanding of the implications of their diagnosis and how to optimise their health. This cluster randomised control trial hypothesises that the combination of early primary care CKD education, and motivational interviewing (MI)-based health coach support, will improve patient behaviours aligned with BP control by increasing patient knowledge, self-efficacy and motivation. The results will aid in sustainable interventions for future patient-centric education and coaching support to improve quality and outcomes in patients with CKD stages 3–5. Outcomes in patients with CKD stages 3–5 receiving the intervention will be compared with similar patients within a control group. Continuous quality improvement (CQI) and systems methodologies will be used to optimise resource neutrality and leverage existing technology to support implementation and future dissemination. The innovative approach of this research focuses on the importance of a multidisciplinary team, including off-site patient coaching, that can intervene early in the CKD care continuum by supporting patients with education and coaching. Methods and analysis We will test impact of BP control when clinician-delivered education is followed by 12 months of MI-based health coaching. We will compare outcomes in 350 patients with CKD stages 3–5 between intervention and control groups in primary care. CQI and systems methodologies will optimise education and coaching for future implementation and dissemination. Ethics and dissemination This study was approved by the University of Michigan Institutional Review Boards (IRBMED) HUM00136011, HUM00150672 and SITE00000092 and the results of the study will be published on ClinicalTrials.gov, in peer-reviewed journals, as well as conference abstracts, posters and presentations. Trial registration number NCT04087798.